Search Results - "Horn, L."

Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331 by Spigel, D.R., Vicente, D., Ciuleanu, T.E., Gettinger, S., Peters, S., Horn, L., Audigier-Valette, C., Pardo Aranda, N., Juan-Vidal, O., Cheng, Y., Zhang, H., Shi, M., Luft, A., Wolf, J., Antonia, S., Nakagawa, K., Fairchild, J., Baudelet, C., Pandya, D., Doshi, P., Chang, H., Reck, M.

“…Patients with relapsed small-cell lung cancer (SCLC) have few treatment options and dismal survival. Phase I/II data show activity of nivolumab in previously…”
Get full text

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008 by Pfaller, Michael A, Andes, David R, Diekema, Daniel J, Horn, David L, Reboli, Annette C, Rotstein, Coleman, Franks, Billy, Azie, Nkechi E

“…This analysis describes the epidemiology and outcomes of invasive candidiasis caused by non-albicans species of Candida in patients enrolled in the Prospective…”
Get full text

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry by Horn, David L., Neofytos, Dionissios, Anaissie, Elias J., Fishman, Jay A., Steinbach, William J., Olyaei, Ali J., Marr, Kieren A., Pfaller, Michael A., Chang, Chi-Hsing, Webster, Karen M.

“…Background. Candidemia remains a major cause of morbidity and mortality in the health care setting, and the epidemiology of Candida infection is changing…”
Get full text

TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer by Oxnard, G.R., Yang, J.C.-H., Yu, H., Kim, S.-W., Saka, H., Horn, L., Goto, K., Ohe, Y., Mann, H., Thress, K.S., Frigault, M.M., Vishwanathan, K., Ghiorghiu, D., Ramalingam, S.S., Ahn, M.-J.

“…Osimertinib is a potent, third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). The multi-arm phase Ib TATTON study…”
Get full text

Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer by Horn, L.-C, Fischer, U, Raptis, G, Bilek, K, Hentschel, B

“…Abstract Objectives Tumor size is a well recognized prognostic factor in early stage cervical carcinoma (CX). However, limited knowledge exists about the value…”
Get full text

Ultrasound guidance compared with electrical neurostimulation for peripheral nerve block: a systematic review and meta-analysis of randomized controlled trials by Abrahams, M.S., Aziz, M.F., Fu, R.F., Horn, J.-L.

“…Despite the growing interest in the use of ultrasound (US) imaging to guide performance of regional anaesthetic procedures such as peripheral nerve blocks,…”
Get full text

Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study by Prentice, R. L., Pettinger, M. B., Jackson, R. D., Wactawski-Wende, J., LaCroix, A. Z., Anderson, G. L., Chlebowski, R. T., Manson, J. E., Van Horn, L., Vitolins, M. Z., Datta, M., LeBlanc, E. S., Cauley, J. A., Rossouw, J. E.

“…Summary The Women's Health Initiative (WHI) double-blind, placebo-controlled clinical trial randomly assigned 36,282 postmenopausal women in the U.S. to…”
Get full text

Role of Cholesterol‐Associated Steatohepatitis in the Development of NASH by Horn, Christian L., Morales, Amilcar L., Savard, Christopher, Farrell, Geoffrey C, Ioannou, George N.

“…The rising prevalence of nonalcoholic fatty liver disease (NAFLD) and NAFLD‐related cirrhosis in the United States and globally highlights the need to better…”
Get full text

Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases by Vokes, E.E., Ready, N., Felip, E., Horn, L., Burgio, M.A., Antonia, S.J., Arén Frontera, O., Gettinger, S., Holgado, E., Spigel, D., Waterhouse, D., Domine, M., Garassino, M., Chow, L.Q.M., Blumenschein, G., Barlesi, F., Coudert, B., Gainor, J., Arrieta, O., Brahmer, J., Butts, C., Steins, M., Geese, W.J., Li, A., Healey, D., Crinò, L.

“…Long-term data with immune checkpoint inhibitors in non-small-cell lung cancer (NSCLC) are limited. Two phase III trials demonstrated improved overall survival…”
Get full text

Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis by Pappas, Peter G., Rotstein, Coleman M. F., Betts, Robert F., Nucci, Marcio, Talwar, Deepak, De Waele, Jan J., Vazquez, Jose A., Dupont, Bertrand F., Horn, David L., Ostrosky-Zeichner, Luis, Reboli, Annette C., Suh, Byungse, Digumarti, Raghunadharao, Wu, Chunzhang, Kovanda, Laura L., Arnold, Leah J., Buell, Donald N.

“…Background. Invasive candidiasis is an important cause of morbidity and mortality among patients with health care–associated infection. The echinocandins have…”
Get full text

Circadian timing and alignment in healthy adults: associations with BMI, body fat, caloric intake and physical activity by Baron, K G, Reid, K J, Kim, T, Van Horn, L, Attarian, H, Wolfe, L, Siddique, J, Santostasi, G, Zee, P C

“…Introduction: Disruption of circadian rhythms is one of the proposed mechanisms linking late sleep timing to obesity risk but few studies have evaluated…”
Get full text

Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial by Hui, R., Garon, E.B., Goldman, J.W., Leighl, N.B., Hellmann, M.D., Patnaik, A., Gandhi, L., Eder, J.P., Ahn, M.-J., Horn, L., Felip, E., Carcereny, E., Rangwala, R., Lubiniecki, G.M., Zhang, J., Emancipator, K., Roach, C., Rizvi, N.A.

“…Pembrolizumab improved survival as first- and second-line therapy compared with chemotherapy in patients with highly programmed death ligand 1 (PD-L1)…”
Get full text

Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial by Mansfield, A.S., Każarnowicz, A., Karaseva, N., Sánchez, A., De Boer, R., Andric, Z., Reck, M., Atagi, S., Lee, J.-S., Garassino, M., Liu, S.V., Horn, L., Wen, X., Quach, C., Yu, W., Kabbinavar, F., Lam, S., Morris, S., Califano, R.

“…The addition of atezolizumab to carboplatin and etoposide (CP/ET) significantly improved progression-free and overall survival for patients with…”
Get full text

A phase III, randomized, open-label study of ASP8273 versus erlotinib or gefitinib in patients with advanced stage IIIB/IV non-small-cell lung cancer by Kelly, R.J., Shepherd, F.A., Krivoshik, A., Jie, F., Horn, L.

“…ASP8273, a novel, small molecule, irreversible tyrosine kinase inhibitor (TKI) specifically inhibits the epidermal growth factor receptor (EGFR) in patients…”
Get full text

An integrated risk and epidemiological model to estimate risk-stratified COVID-19 outcomes for Los Angeles County: March 1, 2020-March 1, 2021 by Horn, Abigail L, Jiang, Lai, Washburn, Faith, Hvitfeldt, Emil, de la Haye, Kayla, Nicholas, William, Simon, Paul, Pentz, Maryann, Cozen, Wendy, Sood, Neeraj, Conti, David V

“…The objective of this study was to use available data on the prevalence of COVID-19 risk factors in subpopulations and epidemic dynamics at the population…”
Get full text

Immunometabolic Status of COVID-19 Cancer Patients by Sica, A, Colombo, M P, Trama, A, Horn, L, Garassino, M C, Torri, V

“…Cancer patients appear to be more likely to be diagnosed with coronavirus disease 2019 (COVID-19). This is supported by the understanding of immunometabolic…”
Get full text

Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals by West, Nicholas P, Horn, Peggy L, Pyne, David B, Gebski, Val J, Lahtinen, Sampo J, Fricker, Peter A, Cripps, Allan W

“…Summary Background & aims To examine the effect of supplementation with probiotics on respiratory and gastrointestinal illness in healthy active men and women…”
Get full text

DNA analysis of traded shark fins and mobulid gill plates reveals a high proportion of species of conservation concern by Steinke, Dirk, Bernard, Andrea M., Horn, Rebekah L., Hilton, Paul, Hanner, Robert, Shivji, Mahmood S.

“…Continuously increasing demand for plant and animal products causes unsustainable depletion of biological resources. It is estimated that one-quarter of sharks…”
Get full text

Effect of mobile food environments on fast food visits by García Bulle Bueno, Bernardo, Horn, Abigail L., Bell, Brooke M., Bahrami, Mohsen, Bozkaya, Burçin, Pentland, Alex, de la Haye, Kayla, Moro, Esteban

“…Poor diets are a leading cause of morbidity and mortality. Exposure to low-quality food environments saturated with fast food outlets is hypothesized to…”
Get full text

Predictors of Time Spent in Special Education Among Students With Severe‐to‐Profound Hearing Loss by Epstein, Sherise, Ngo, LizAnne, Sanders, Elizabeth A., Horn, David L.

“…Objective Determine if students with severe‐to‐profound hearing loss with cochlear implants (CIs) mainstream (transition to general education) more than…”
Get full text